| Followers | 28 |
| Posts | 4993 |
| Boards Moderated | 0 |
| Alias Born | 09/22/2006 |
Tuesday, June 10, 2008 11:05:54 PM
Rod: In reviewing your post I took particular interest in your statement: The Phase I Cheetah data was absolutely fantastic!!!
Any longterm HTI/HALO investor knows that it is a significantly bullish signal when you use exclamation points. And here you choose to use three!!! Certainly somthing to pay attention to IMHO.
As for the quietude of the board in response to the phase I Cheetah data, I am not so surprised at the lack of comment as this was in no way unexpected. However, the rest of your comment is really where the matter lays at this point in time, i.e., how and when does HALO capitalize on this fantastic development.
I recall several conf. calls ago that Dr. Lim stated that HALO employs 2 full time staff in the pursuit of partnerships. The analysts on the call gave that info a big ho-hum, but HALO is not in the business of wasting capital, so I've always felt that we could get partnership news out of the blue at any time. That feeling is stronger than ever in light of the Cheetah developments. This is huge and we are truly at the cusp of a memorable pivot point in the development of HALO and the pps.
Very exciting times indeed, despite the quiet. Calm before the storm,IMHO.
Good luck!
-Fritz
Any longterm HTI/HALO investor knows that it is a significantly bullish signal when you use exclamation points. And here you choose to use three!!! Certainly somthing to pay attention to IMHO.
As for the quietude of the board in response to the phase I Cheetah data, I am not so surprised at the lack of comment as this was in no way unexpected. However, the rest of your comment is really where the matter lays at this point in time, i.e., how and when does HALO capitalize on this fantastic development.
I recall several conf. calls ago that Dr. Lim stated that HALO employs 2 full time staff in the pursuit of partnerships. The analysts on the call gave that info a big ho-hum, but HALO is not in the business of wasting capital, so I've always felt that we could get partnership news out of the blue at any time. That feeling is stronger than ever in light of the Cheetah developments. This is huge and we are truly at the cusp of a memorable pivot point in the development of HALO and the pps.
Very exciting times indeed, despite the quiet. Calm before the storm,IMHO.
Good luck!
-Fritz
The more you know, the less you don't know.
Recent HALO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:29:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:28:38 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 10:35:07 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/23/2026 08:16:26 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/23/2026 08:13:32 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/23/2026 08:11:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 12:32:00 PM
- Halozyme Appoints David Ramsay as Interim Chief Financial Officer • PR Newswire (US) • 03/12/2026 12:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/10/2026 08:05:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/09/2026 08:18:04 PM
- U.S. FDA Approves TECVAYLI® in Combination with DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma • PR Newswire (US) • 03/06/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 11:56:16 PM
- Halozyme to Participate in Upcoming Investor Conferences • PR Newswire (US) • 02/25/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 11:19:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 11:16:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 11:12:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 11:53:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 11:52:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 11:51:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 09:04:55 PM
- HALOZYME REPORTS FULL YEAR 2025 RECORD REVENUE OF $1.4 BILLION AND REITERATES STRONG 2026 FINANCIAL GUIDANCE • PR Newswire (US) • 02/17/2026 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2026 02:21:33 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2026 02:20:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2026 02:20:34 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2026 01:56:32 AM
